HKUST Spearheads Four Large AI Models to Revolutionize Healthcare

October 31, 2024 09:46 AM EDT | By Cision
 HKUST Spearheads Four Large AI Models to Revolutionize Healthcare
Image source: Kalkine Media

HONG KONG, Oct. 31, 2024 /PRNewswire/ -- In a groundbreaking initiative, The Hong Kong University of Science and Technology (HKUST) has unveiled four AI-driven models poised to transform the medical and healthcare fields. These AI models can assist both general and specialist medical practitioners in diagnosing and prognosing up to 30 types of cancers and diseases, with some achieving accuracy comparable to that of medical experts with five years of experience or more.

Supported by the University's new AI supercomputing facility, which offers robust computing power, these large AI models surpass many existing systems due to their foundation on extensive data sets and novel machine training strategies.  Prof. CHEN Hao, Assistant Professor in the Department of Computer Science and Engineering and project lead, said that one model processed over 160 million images across 32 cancer types for pathological diagnostic tasks.

The four models include:

  • MOME (Breast Cancer Diagnosis) - This is the first adaptation of a large foundation model for 3D mpMRI fusion. Targeting breast cancer, one of the most prevalent cancers among females in Hong Kong, MOME distinguishes malignant from benign breast lumps using MRI scans, achieving accuracy levels comparable to radiologists with 5 or more years of experience. It provides an alternative to the more intrusive diagnostic form of biopsies. Additionally, it predicts patients' responses to neoadjuvant chemotherapy, enabling non-invasive and personalized management of breast cancer.
  • mSTAR (Pathology Assistant Tool) - Pathological examination is the gold standard in cancer diagnosis, but generating pathology reports can be time-consuming and prone to errors. mSTAR, recognized as one of the world's leading foundation models, aims to streamline this process. Unlike existing ones that analyze slides by splitting them into individual patches, mSTAR stands out by directly modelling whole slide images and augmenting with multimodal knowledge, further enhancing accuracy. It assists pathologists in performing up to 40 diagnostic and prognostic tasks, significantly reducing examination time and improving diagnostic consistency.  
  • MedDr (Generalist) - This versatile AI medical generalist functions like a "medical GPT". The multimodal language model can answer questions, generate medical reports, and provide initial diagnoses based on medical images. As one of the largest open-source generalist foundation models tailored for medicine, MedDr helps physicians make faster and more accurate diagnoses. A recent study by Shanghai AI Lab recognized it as one of the best existing generalist models.
  • XAIM (Explainable AI) - This novel framework enhances healthcare professionals' confidence in adopting AI by explaining how medical AI models reach their decisions. While many AI models offer high accuracy, they often lack transparency, leading to skepticism. XAIM addresses this by providing visual and textual explanations of the models' analyses.

Prof. Chen, also the Director of the Collaboration Center for Medical and Engineering Innovation, jointly established between HKUST and Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, stated, "We hope our AI tools will serve as valuable assistants for doctors, improving diagnostics, personalizing treatment plans, and streamlining different tasks. Building on our success, we are developing a wide range of AI applications targeting various clinical tasks, particularly precision oncology and computer-assisted intervention, while continuously enhancing our models with more data and modalities. By collaborating closely with clinical partners, we aim to drive improvements in patient care over the long term."

As a leader in AI research, HKUST has made significant contributions to medicine, including an AI model predicting the prognosis of brain tumor patients, a highly accurate blood test for early detection of Alzheimer's disease and mild cognitive impairment, and a microscope aiding near real-time judgments in lung cancer surgery, sparing patients' unnecessary procedures.

Video: https://www.youtube.com/watch?v=AET5DOWHeHo

Download photos here: https://geco.ust.hk/download/press_release/1031%20AI%20doctor/Photo/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media Incorporated (“Kalkine Media, we or us”), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used in the Content are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Canadian AI All-Stars: Unveiling the Top Stocks for 2025

Send OTP Resend OTP in 30s

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.